Compare Airway Medix SA with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
PLN 34 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.34
70.55%
-3.33
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.97%
0%
-7.97%
6 Months
-19.58%
0%
-19.58%
1 Year
10.27%
0%
10.27%
2 Years
7.75%
0%
7.75%
3 Years
-6.13%
0%
-6.13%
4 Years
-56.16%
0%
-56.16%
5 Years
-82.91%
0%
-82.91%
Airway Medix SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.66%
EBIT Growth (5y)
-192.42%
EBIT to Interest (avg)
-1.67
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.79
Sales to Capital Employed (avg)
0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
1.74%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-4.46
EV to EBIT
-8.36
EV to EBITDA
-8.42
EV to Capital Employed
15.34
EV to Sales
51.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-183.60%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-7.10
-6.00
-18.33%
Interest
1.90
6.20
-69.35%
Exceptional Items
10.00
0.00
Consolidate Net Profit
1.70
-11.70
114.53%
Operating Profit Margin (Excl OI)
-1,808,250.00%
-504,833.30%
-1,30,341.67%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 114.53% vs -254.55% in Dec 2024
About Airway Medix SA 
Airway Medix SA
Pharmaceuticals & Biotechnology
Airway Medix SA is a Poland-based company engaged in the biotechnology and medical research industry. The Company focuses on the research, development and commercialization of devices for single use in mechanically ventilated patients in intensive care units (ICU), and patients with life-threatening and anesthesiology division. It offers closed suction system, a closed cleaning system for simple hygiene treatment, endotracheal intubation tubes and oral care solution for cleaning the mouth.
Company Coordinates 
Company Details
Ul. Gen. Jozefa Zajaczka 11/14 , WARSZAWA None : 01-510
Registrar Details






